SPNZF yields 3.23% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, SPNZF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SPNZF + JNJ for your $10,000?
South Port New Zealand Limited operates and manages a port in New Zealand. It offers marine services, including shipping movements, pilotage and procedures, cruise schedules, marine plant and equipment, wind and tide conditions, syncrolift, and hot work; port facilities, such as port infrastructure; berths; infrastructure and land; plant and equipment; and weighbridge services; container servicing and rates, and container tracking services; and cold storage and dry warehousing services. The company also provides full container, break bulk, and bulk cargo capability and services for the import of alumina, petroleum products, fertilizers, acids, stock food, and cement; and the export of aluminum, timber, logs, dairy, meat by-products, fish, and woodchips. In addition, it handles project cargo, such as transformer weighing; wind farm material, which include twin cranes lifts and a maximum lift of 80 metric tonnes; hydroelectric power station tail race equipment; mining equipment that comprise bucket wheel excavators and dump trucks; tanks for tallow storage, as well as a range of machinery, including pleasure and fishing vessels; and operates intermodal freight center. South Port New Zealand Limited was incorporated in 1988 and is based in Bluff, New Zealand.
Full SPNZF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.